Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

gsk_l_rgb-web

GSK establish cell and gene therapy collaboration with Miltenyi Biotec

March 16, 2016 Medical Communications, Research and Development GSK, GlaxoSmithKline, cell and gene therapy, collaboration, miltenyi biotec

GlaxoSmithKline (NYSE:GSK) has announced a strategic collaboration with Miltenyi Biotec that will see GSK’s expertise in developing cell and gene …
News

Blueprint Medicines agrees $1 billion-plus deal with Roche for cancer therapy

March 16, 2016 Business Services, Research and Development, Sales and Marketing Blueprint Medicines, Deals, Immunokinases, Roche, drug development

Blueprint Medicines Corp (Nasdaq: BPMC) said it has signed an over $1 billion deal with oncology drug giant Roche (SIX: ROG) …
News
aedes_aegypti_mosquito

New research supports association between Zika virus and microcephaly

March 16, 2016 Medical Communications, Research and Development Lancet, Zika virus, french polynesia, microcephaly, outbreak

Using data from the 2013-14 outbreak of Zika virus in French Polynesia, new research in The Lancet has further supported …
News
bruce_roberts_vedanta

PureTech’s Vedanta Biosciences appoints former Genzyme VP chief scientific officer

March 16, 2016 Medical Communications, Research and Development Bruce Roberts, Genzyme, Vedanta Biosciences

Vedanta Biosciences, a company developing therapies designed to modulate the human microbiome, has appointed former Genzyme group vice president, Bruce …
Appointment
celatorpharmalogo

Celator’s shares jump on positive late-stage trials for leukaemia drug

March 16, 2016 Business Services, Research and Development, Sales and Marketing Celator Pharmaceuticals, EMA, US FDA, Vyxeos, drug trials, phase III

Shares in trial-stage Celator Pharmaceuticals (Nasdaq: CPXX) soared gaining over four times in value as the company announced late-stage trials …
News
abbottweb

FDA says benefits outweigh risks in Abbott’s heart stent, Absorb

March 16, 2016 Research and Development, Sales and Marketing Abbott, absorb, bioresorbable, coronary artery disease

An independent panel convened by the US Food and Drug Administration (FDA) has unanimously voted that the benefits of Absorb, …
News
sanofi_dice

Sanofi to use DiCE Molecules’ platform to boost drug discovery

March 16, 2016 Research and Development DiCE Molecules, Sanofi

Sanofi has announced a research partnership with newly-launched DiCE Molecules in which the French pharma giant will use DiCE’s small …
News
teva_copy

Teva says closing buy of Allergan’s generics biz may take longer

March 16, 2016 Business Services, Research and Development, Sales and Marketing Allergan, M&A, MA, Pfizer, Teva

Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA) said its $40.5 billion acquisition of Allergan’s generics business will take longer than expected, …
News
eli_lilly

Lilly changes Alzheimer’s trial endpoint – shares fall

March 16, 2016 Research and Development Alzheimer's disease, Eli Lilly, solanezumab

Shares in Eli Lilly fell more than 4% yesterday when it announced it was changing the primary endpoint of a closely-watched …
News
shutterstock_244903099

InVivo Therapeutics to sell stake in company; shares drop

March 15, 2016 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing InVivo Therapeutics, Stake sale, stocks

InVivo Therapeutics (Nasdaq: NVIV) said it plans to sell an additional stake in the company to raise funds for its ongoing …
News

PTC Therapeutics to file new Phase III data for genetic muscle disorder drug in Canada

March 15, 2016 Manufacturing and Production, Research and Development Canada, PTC Therapeutics, Translarna, nonsense mutation Duchenne muscular dystrophy, phase III

PTC Therapeutics (Nasdaq: PTCT) said it does not expect the Canadian regulators to review its trial drug to treat a …
News
adocia_lilly

Adocia and Lilly report positive early results for ultra-rapid insulin

March 15, 2016 Manufacturing and Production, Research and Development Adocia, BioChaperone Lispro, Eli Lilly, insulinm

Eli Lilly and development partner Adocia have announced today positive topline results from a Phase 1b clinical trial of ultra-rapid …
News

UPDATE: Pfizer gets interim stay on cough syrup ban

March 15, 2016 Manufacturing and Production, Research and Development Abbott Laboratories, Corex, Pfizer, Pfizer India

Shares in Pfizer India continued to tumble for a second day even as an Indian court granted the company a …
News

Genentech cancer immunotherapy gets Priority FDA Review in bladder cancer

March 15, 2016 Manufacturing and Production, Research and Development FDA, Genentech, Roche, atezolizumab, bladder cancer, priority review

The US FDA has granted Roche subsidiary Genentech a Priority Review for atezolizumab in treating advanced bladder cancer, whose disease …
News
gwpharma

GW Pharma shares more than double after positive Phase III trials for epilepsy drug

March 15, 2016 Manufacturing and Production, Research and Development Epidiolex, GW Pharma, US FDA, epilepsy in children, phase III

Shares in UK-based GW Pharmaceuticals (Nasdaq: GWPH) more than doubled on the Nasdaq Monday after the company announced positive results …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025